/ Not yet recruitingPhase 2 Pharmacokinetic Study of Palmitoylethanolamide (PEA) Extract in Healthy Human Volunteers. - Nil
/ Not yet recruitingPhase 2 Clinical Pharmacokinetic Study of Quercetin Extracts in Healthy Human Volunteers. - Nil
/ CompletedNot Applicable Effect and Tolerance of Standardized Exclusive Dry Extracts of Curcuma Longa (CURTIL03) and of Boswellia Serrata (BOSTIL01) in Support of Standard Treatments Among People With Hand Joint Discomfort and Dysfunction: a Multicenter Hospital Setting, Randomized, Blinded, Placebo-controlled Clinical Study.
The objective of the study is to evaluate the effect and tolerance of standardized exclusive dry extracts of Curcuma longa (CURTIL03) and of Boswellia serrata (BOSTIL01) among people with hand joint discomfort and dysfunction.
The study is prospective, randomized, double-blinded, placebo-controlled with 2 parallel-groups in 200 participants. The study is multicentric and will be done by 11 investigators located in Belgium including rheumatologists, sports and rehabilitation physicians, physical therapists, or any hand articular disease specialists.
100 Clinical Results associated with Tilman SA
0 Patents (Medical) associated with Tilman SA
100 Deals associated with Tilman SA
100 Translational Medicine associated with Tilman SA